(A) Box and whisker plots representing the median concentration (1st -99th percentile) of C26:0-carnitine in male controls, X-ALD patients, female controls and heterozygous females
(B) C26:0-LPC in male controls, X-ALD patients, female controls and heterozygous females.
(C) Spearman's correlation between C26:0-carnitine and C26:0-LPC in X-ALD patients.
Conc. – concentration; dotted lines represent the respective cut-off points for C26:0-carnitine and C26:0-LPC.